Related references
Note: Only part of the references are listed.Clinical and pathological analysis of giant cell tumor of bone with denosumab treatment and local recurrence
Kenta Hayashida et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2022)
Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum
Haijie Liang et al.
SPINE (2022)
Stereotactic body radiotherapy for lung metastases in a patient with giant cell tumor of bone: a case report and literature review
Liwen Feng et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Efficacy of Pazopanib in the Treatment of Metastatic Malignant Giant Cell Tumor of Soft Tissue: A Case Report
Tadashi Iwai et al.
CURRENT ONCOLOGY (2022)
Multiple Pulmonary Metastases of Recurrent Giant Cell Tumor of Bone with Expression of VEGFR-2 Successfully Controlled by Denosumab and Apatinib: A Case Report and Literature Review
Taojun Gong et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Current Concepts in the Treatment of Giant Cell Tumors of Bone
Shinji Tsukamoto et al.
CANCERS (2021)
Objective response of denosumab for multiple pulmonary metastases from giant cell tumor of bone: A case report and review of the literature
Ikuo Kudawara et al.
CURRENT PROBLEMS IN CANCER: CASE REPORTS (2021)
Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology
Mathilde Treffel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
Suraj Hindiskere et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2020)
Outcome of lung metastases due to bone giant cell tumor initially managed with observation
Shinji Tsukamoto et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2020)
Neoadjuvant denosumab ITS ROLE AND RESULTS IN OPERABLE CASES OF GIANT CELL TUMOUR OF BONE
A. Puri et al.
BONE & JOINT JOURNAL (2019)
Denosumab and Sunitinib in the treatment of giant-cell tumor of bone with pulmonary and bone metastases in an adolescent A case report
Guannan Wang et al.
MEDICINE (2019)
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2019)
Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab
Pramod Shekarappa Chinder et al.
CLINICS IN ORTHOPEDIC SURGERY (2019)
Efficacy and Limitations of F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography to Differentiate Between Malignant and Benign Bone and Soft Tissue Tumors
Shinji Miwa et al.
ANTICANCER RESEARCH (2018)
Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage
Costantino Errani et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2018)
Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone
Yi Luo et al.
Cancer Management and Research (2018)
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
Jacob Engellau et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India
Bharat Rekhi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E. Palmerini et al.
EUROPEAN JOURNAL OF CANCER (2017)
Surveillance for lung metastasis from giant cell tumor of bone
Mamer Rosario et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Giant Cell Tumor of the Rib: Two Cases of F-18 FDG PET/CT Findings
Hye Lim Park et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Disappearance of giant cells and presence of newly formed bone in the pulmonary metastasis of a sacral giant-cell tumor following denosumab treatment: A case report
Tetsuro Yamagishi et al.
ONCOLOGY LETTERS (2016)
Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone
Frank Traub et al.
EUROPEAN JOURNAL OF CANCER (2016)
Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series
Daniel A. Mueller et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Risk Factors for Pulmonary Metastases from Giant Cell Tumor of Bone
Chung Ming Chan et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2015)
Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
Michiyuki Hakozaki et al.
DIAGNOSTIC PATHOLOGY (2014)
Pigmented villous nodular synovitis mimicking metastatic melanoma on PET-CT
Luke Selby et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2014)
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
Sant Chawla et al.
LANCET ONCOLOGY (2013)
Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT
Manabu Hoshi et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2012)
Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone
Daniel G. Branstetter et al.
CLINICAL CANCER RESEARCH (2012)
A Case of Giant Cell Tumor of Sacrum With Unusual Pulmonary Metastases CT and FDG PET Findings
Yuyang Zhang et al.
CLINICAL NUCLEAR MEDICINE (2012)
Giant Cell Tumor Pulmonary Metastases Mimic Primary Malignant Pulmonary Nodules on 18F-FDGPET/CT
William Makis et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Clinical use of denosumab for the treatment for postmenopausal osteoporosis
E. Michael Lewiecki
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
David Thomas et al.
LANCET ONCOLOGY (2010)
Interferon Alfa-2b for Recurrent and Metastatic Giant Cell Tumor of the Spine Report of Two Cases
Feng Wei et al.
SPINE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
2-[18F]-2-Deoxy-D-Glucose (FDG) Uptake in Human Tumor Cells is Related to the Expression of GLUT-1 and Hexokinase II
L. -C. Ong et al.
ACTA RADIOLOGICA (2008)
Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India
R. Gupta et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2008)
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II
Kenichiro Hamada et al.
ANNALS OF NUCLEAR MEDICINE (2008)
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone Metastases
Allan Lipton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Histologically verified lung metastases in benign giant cell tumours - 14 cases from a single institution
M. Dominkus et al.
INTERNATIONAL ORTHOPAEDICS (2006)
Denosumab in postmenopausal women with low bone mineral density
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
PJ Bekker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation
YC Fu et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Hypoxia-induced gene expression in human macrophages - Implications for ischemic tissues and hypoxia-regulated gene therapy
B Burke et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions
J Aoki et al.
RADIOLOGY (2001)
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
DL Lacey et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappa B in giant cell tumor of bone - Possible involvement in tumor cell-induced osteoclast-like cell formation
L Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
